Singular Health Group Ltd (ASX:SHG)
0.2500
-0.0050 (-1.96%)
At close: Jan 22, 2026
Singular Health Group Revenue
In the fiscal year ending June 30, 2025, Singular Health Group had annual revenue of 557.61K AUD, down -40.30%. Singular Health Group had revenue of 482.23K in the half year ending June 30, 2025.
Revenue
557.61K
Revenue Growth
-40.30%
P/S Ratio
141.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
78.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 557.61K | -376.47K | -40.30% |
| Jun 30, 2024 | 934.07K | 491.73K | 111.17% |
| Jun 30, 2023 | 442.34K | 24.20K | 5.79% |
| Jun 30, 2022 | 418.14K | -40.28K | -8.79% |
| Jun 30, 2021 | 458.42K | 331.32K | 260.66% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alcidion Group | 40.79M |
| Mach7 Technologies | 33.79M |
| Beamtree Holdings | 28.60M |
| ImExHS | 26.32M |
| PharmX Technologies | 7.53M |
| Vitasora Health | 3.71M |
| PainChek | 3.36M |
| Emyria | 1.39M |